Company Description

We are delighted to be opening our new facility in Rockville, GSK’s first fully dedicated vaccines R&D center located in the US. Our investment here signifies our commitment to discovering and developing new vaccines across a range of pressing public health priorities, including those important here in the US. It places GSK at the heart of a dynamic and cutting edge bioscience hub in Washington, D.C. We look forward to fruitful partnerships and collaborations in this community to advance the science of vaccines, and help improve health of millions of people around the world.”

Members

  • No members are assigned.